IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

TRV GP IV, LLC

Q4 2019 Holdings

Filed 2020-02-05 | 2 holdings | $160.4K | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Magenta Therapeutics, Inc.COM55910K108$121.4K8,008,20475.7%
Fulcrum Therapeutics, Inc.(FULC)COM359616109$39.0K2,343,15424.3%